First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer
Clinical trial NCT07756281 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07756281
- Sponsor
- Synnovation Therapeutics, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2029-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.